藥碼
PIT02
藥名
Vasopressin 針 20 IU/1 mL/Amp
英文商品名
Pitressin 針 20 IU/1 mL/Amp
中文商品名
必壓生注射劑
螢幕名
Pitressin 針 20 IU/1 mL/Amp
劑型
Inj
規格
Inj 20 IU/ml/Amp (aqueous solution)
成分
藥理分類
Pituitary Hormones
健保碼
AC33429238
ATC碼
藥品圖片
外觀圖片
適應症
#建議持續輸注 (IV pump) 之高警訊藥品

Septic shock and other vasodilatory shock states: To increase BP in adults with vasodilatory shock (eg, postcardiotomy or sepsis) who remain hypotensive despite fluid resuscitation and catecholamines
藥理
Antidiuretic Hormone Analog
Antidiuretic (central diabetes insipidus) effect; at greater than physiologic doses, vasopressin has a pressor effect due to vasoconstriction and causes contraction of the smooth muscle of the gastrointestinal tract.
藥動學
Absorption:
1. None from GI tract, destroyed by trypsin in GI tract, must be administered parenterally
2. Duration: (Antidiuretic) 2 to 8 hours; (Vasopressor effect) Within 20 minutes after IV infusion terminated
Distribution:
1. Vd: 140 mL/kg
2. Protein binding: None
Metabolism:
Hepatic, renal (inactive metabolites)
Excretion:
1. SUBQ: Urine (5% as unchanged drug) after 4 hours
2. IV: Urine (~6% as unchanged drug)
3. Half-life elimination: 10 to 20 minutes
禁忌症
1. Anaphylaxis or hypersensitivity to the components
2. Hypersensitivity to chlorobutanol
懷孕分類
C
哺乳分類
Enters breast milk/use caution
副作用
1. Cardiovascular: Atrial fibrillation, bradycardia, ischemic heart disease, limb ischemia (distal), low cardiac output, right heart failure, shock (hemorrhagic)
2. Dermatologic: Skin lesion (ischemic)
3. Endocrine & metabolic: Hyponatremia
4. Gastrointestinal: Mesenteric ischemia
5. Hematologic & oncologic: Decreased platelet count, hemorrhage
6. Hepatic: Increased serum bilirubin
7. Renal: Renal insufficiency
8. Postmarketing: Diabetes insipidus (reversible)
劑量和給藥方法
Shock, sepsis:
1. Initial: 0.03 units/min added to norepinephrine as a fixed dose (not titrated); usual dosage range 0.01 to 0.04 units/minute
2. Doses >0.04 units/minute should be reserved for salvage therapy due to potential risk of ischemic complications (eg, skin, cardiac, splanchnic)
Shock, post-cardiotomy:
1. Initial: 0.03 units/minute; If the target blood pressure response is not achieved, titrate up by 0.005 units/minute at 10- to 15-minute intervals (maximum dose: 0.1 units/minute)
2. After target blood pressure has been maintained for 8 hours without the use of catecholamines, taper by 0.005 units/minute every hour as tolerated to maintain target blood pressure
小兒調整劑量
腎功能調整劑量
There are no dosage adjustments provided in the manufacturer's labeling.
肝功能調整劑量
There are no dosage adjustments provided in the manufacturer's labeling.
安定性
注射給藥指引
給藥途徑
IV pump (持續靜脈輸注)
靜脈輸注液
NS、D5W (MDX)
每瓶稀釋液體積
-
注射濃度
限水病人: 1 unit/mL、非限水病人: 0.1 unit/mL (MDX)
給藥速率
詳見「劑量和給藥方法」
安定性
注意事項
相容:aminophylline, amiodarone, bumetanide, calcium chloride, calcium gluconate, cisatracurium, dexmedetomidine, diltiazem, dobutamine, dopamine, epinephrine, esmolol, fentanyl, heparin, Isoproterenol, insulin, lansoprazole, lidocaine, lorazepam, magnesium sulfate, manitol, midazolam, milrinone, nicardipine, nitroglycerin, norepinephrine, octreotide, pantoloc, potassium chloride, sodium bicarbonate
不相容:furosemide

完整資訊請見重症常用藥品靜脈相容性表
藥袋資訊
臨床用途
低血壓、休克
主要副作用
腹痛、腹瀉、暈眩、流汗、噁心或嘔吐、皮膚蒼白等
泡製方法
儲存方式
請置於 15-30℃ 乾燥處儲存
注意事項
其他說明
藥局 f2 | 藥庫 注G12 <自批號305514起,藥品標籤顏色變更。20241115>
藥品外觀
顏色
形狀
剝痕
標記1
標記2
其他
健保藥價
216
自費價
287.28
仿單
資料庫
健保給付規定